
Valnate 333mg/145mg Tablet CR
Marketer
Shatayushi Healthcare Pvt Ltd
Salt Composition
Sodium Valproate (333mg) + Valproic Acid (145mg)
Overview Valnate 333mg/145mg Tablet CR
Epileptic seizures, characterized by recurrent fits stemming from abnormal brain activity, are addressed by the dual-action medication, Valnate 333mg/145mg CR Tablet. This formulation regulates neuronal excitability, thus preventing seizure episodes. Administer Valnate with food, as directed by your physician. Dosage adjustments, potentially starting low and gradually increasing to optimal levels, will be determined based on your individual needs. Therapeutic effects may take several weeks to manifest; consistent use is crucial for efficacy. Discontinuation should only occur under medical supervision, as abrupt cessation might trigger increased seizure frequency or exacerbate existing bipolar disorder. Common adverse effects include nausea and tremors, though less frequent reactions such as vomiting, headaches, hepatic dysfunction, and epigastric pain have been reported. Most side effects resolve spontaneously, but persistent or bothersome symptoms necessitate medical consultation. Preventive or mitigating strategies may be available. Prior to commencing Valnate therapy, disclose any pre-existing renal or hepatic impairment, meningitis, depression, or suicidal ideation to your doctor. A complete medication history, including contraceptives, is vital due to potential drug interactions. While Valnate may be prescribed during pregnancy or breastfeeding if absolutely necessary, dosage modifications may be implemented. Avoid operating machinery, including vehicles, if drowsiness or dizziness occurs. Regular blood monitoring will assess treatment response. Alcohol consumption should be avoided to minimize potential side effect exacerbation. Weight gain is a possibility; a balanced diet, reduced high-calorie snacking, and regular exercise are recommended. Report any unusual mood shifts, new or intensified depression, or suicidal thoughts or actions to your healthcare provider immediately.
Primary Ingredients of Valnate 333mg/145mg Tablet CR
The provided text is "undefined". Therefore, no rephrasing is possible.
Uses of Valnate 333mg/145mg Tablet CR
Seizure disorder
Major Benefits of Valnate 333mg/145mg Tablet CR:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Valnate 333mg/145mg CR tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
Common Side effects of Valnate 333mg/145mg Tablet CR:
- Nausea
- Tremors
How to use Valnate 333mg/145mg Tablet CR:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. The Valnate 333mg/145mg Controlled-Release tablet should be administered with a meal.
How Valnate 333mg/145mg Tablet CR works:
Each Valnate CR tablet (333mg/145mg) contains a dual anticonvulsant formulation of valproic acid and sodium valproate.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Valnate 333mg/145mg CR tablets is unsafe.
PregnancyCONSULT YOUR DOCTOR
Use of Valnate 333mg/145mg CR tablets during pregnancy is contraindicated due to established risk to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Extended-release Valnate tablets (333mg/145mg) are considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer into breast milk, posing no known risk to the infant.
DrivingUNSAFE
Taking Valnate 333mg/145mg Controlled-Release tablets might reduce awareness, impair vision, or cause drowsiness and dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
The use of Valnate 333mg/145mg CR tablets in individuals with kidney impairment is likely safe, based on current limited evidence. Dose modification for Valnate 333mg/145mg CR tablets may not be necessary in such cases, but this should be discussed with a physician. Patients with pre-existing kidney conditions should consult their doctor before using this medication.
LiverCAUTION
Patients with liver impairment should use Valnate 333mg/145mg CR tablets cautiously, potentially requiring dose modification. Consult a physician before use. Valnate 333mg/145mg CR tablets are contraindicated in patients with severe or active liver disease.
What if you forget to take Valnate 333mg/145mg Tablet CR :
Should you forget a Valnate 333mg/145mg CR Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Valnate 333mg/145mg Tablet CR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
